How did the Polynovo share price respond last time the company reported?

Polynovo shares will be on watch tomorrow as the company reports its earnings. Let's look back to see what happened last time.

| More on:
Two happy scientists analysing test results in a lab

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Polynovo Ltd (ASX: PNV) share price is having a pretty pleasing day of trade this Thursday. At present, Polynovo shares are up an encouraging 2% at $2.04 each.

That compares well against the S&P/ASX 200 Index (ASX: XJO), which is also in the green, but by 0.76% at about 7,051 points. So a market-beating kind of day for Polynovo shares.

But today is just a warm-up act. Because all eyes will be on this ASX healthcare company tomorrow when it reports its full-year earnings for the 2022 financial year.

Now, we obviously can't predict what is going to happen to Polynovo shares tomorrow from where we stand today. They could go up, go down, or stay flat. But what we can do is take a look at what happened to the Polynovo share price the last time this company reported earnings.

What happened to the Polynovo share price last earnings season?

So Polynovo's last reporting date with ASX investors was back on 25 February of this year. That was when the company dropped its half-year results for FY2022, which covered the six months to 31 December 2021.

As we covered at the time, the company reported a 41.9% surge in revenue to $18.15 million. That led to Polynovo announcing an underlying profit after tax of $1.618 million. That was up from the previous year's loss of $3.57 million.

However, the company still reported a net loss after tax of $1.7 million when non-cash items were excluded.

So how did Polynovo shares react to these earnings? Well, it was an interesting tale.

Upon the release of this report on Friday 25 February, the Polynovo share price ended the trading day with a loss of 3.77%. The following Monday saw the company lose another 1.96%, but the next day the company gained an impressive 10%.

Now this experience in no way tells us what exactly will happen with the Polynovo share price tomorrow. If the results are above the market's expectations, the shares will, in all likelihood, go up. If they are below expectations, the shares might fall. But it's still an interesting insight into what can happen during earnings season.

At the current Polynovo share price, this ASX 200 healthcare share has a market capitalisation of $1.35 billion.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended POLYNOVO FPO. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Healthcare Shares

This ASX All Ords share is diving 18% as inflation pain draws blood

This healthcare company delivered a trading update at its annual general meeting today.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Healthcare Shares

Up 427% this year, why today is a big day for Mesoblast shares

Why is everyone talking about Mesoblast shares on Friday?

Read more »

A man holds his hand under his chin as he concentrates on his laptop screen and reads about the ANZ share price
Healthcare Shares

Is this beaten-down ASX healthcare share a bargain buy now?

One expert has given their view on this stock.

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Healthcare Shares

3 ASX healthcare shares going gangbusters on Thursday

Investors are sending these ASX healthcare stocks soaring today. But why?

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Is it time to cash in on Sigma shares?

Shares have extended after the Chemist Warehouse merger.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Healthcare Shares

Buy this ASX 200 share that is swimming in cash

Bell Potter sees potentially big returns on offer from this cashed-up stock.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Are CSL shares a buy after the biotech's FY25 forecasts?

Brokers continue to weigh in.

Read more »

Female pharmacist smiles with a digital tablet.
Healthcare Shares

Are Wesfarmers or Sigma shares a better buy in the pharmacy arena?

These two stocks are both leaders in the industry.

Read more »